0000000000304063
AUTHOR
Silvia Rosa
showing 3 related works from this author
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagon…
2022
Background: In patients with atrial fibrillation who suffered an ischemic stroke while on treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent ischemic events and major bleedings remain uncertain. Methods: This prospective multicenter observational study aimed to estimate the rates of ischemic and bleeding events and their determinants in the follow-up of consecutive patients with atrial fibrillation who suffered an acute cerebrovascular ischemic event while on nonvitamin K antagonist oral anticoagulant treatment. Afterwards, we compared the estimated risks of ischemic and bleeding events between the patients in whom anticoagulant therapy was chan…
Microstructural characterization of a 3D-printed soil
2022
Transversal applications of 3D-printing (or Additive Manufacturing) have been recently implemented in the field of Geomechanics. In a 3D-printing process, the printed volume is obtained from successive layering of adjacent soil filaments. In this work, the fabric of an as-printed soil has been carried out by combining Mercury Intrusion Porosimetry (MIP) tests and Scanning Electron Microscope (SEM) observations, with the aim to highlight how the particle arrangements and the orientation and shape of pores are linked to the printing operation. The microstructural analyses showed that macropores are the result of the relative position of the filaments and their initial distortion in quasi-undr…
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
2021
Background and Purpose: Clinical trials on stroke prevention in patients with atrial fibrillation have consistently shown clinical benefit from either warfarin or non–vitamin K antagonist oral anticoagulants (NOACs). NOAC-treated patients have consistently reported to be at lower risk for intracerebral hemorrhage (ICH) than warfarin-treated patients. The aims of this prospective, multicenter, multinational, unmatched, case-control study were (1) to investigate for risk factors that could predict ICH occurring in patients with atrial fibrillation during NOAC treatment and (2) to evaluate the role of CHA 2 DS 2 -VASc and HAS-BLED scores in the same setting. Methods: Cases were consecutive pa…